| P50 | author | You Luo | Q57612860 |
| P2093 | author name string | Li Yang | |
| | Sheng-Jun Fu | |
| | Dong-Li She | |
| | Hu Xiong | |
| P2860 | cites work | Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery | Q24614649 |
| | Inflammation and cancer | Q24649640 |
| | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| | Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis | Q27000727 |
| | Cancer-related inflammation | Q27860907 |
| | Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 |
| | Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 |
| | The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals | Q33688733 |
| | The association between statin medication and progression after surgery for localized renal cell carcinoma | Q34206127 |
| | Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database | Q34458822 |
| | Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer. | Q34502662 |
| | Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result | Q34626043 |
| | Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma | Q34757109 |
| | Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database | Q35282895 |
| | Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy | Q36177201 |
| | Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy | Q36267681 |
| | The role of statins in cancer therapy | Q36426621 |
| | Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study | Q36833801 |
| | An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder | Q37245287 |
| | Statins and cancer: A systematic review and meta-analysis | Q37245345 |
| | Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen | Q37632779 |
| | Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy | Q37641097 |
| | Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy? | Q37650468 |
| | Statin use in relation to prostate cancer outcomes in a population-based patient cohort study | Q37667939 |
| | Chronic inflammation and cancer: suppressing the suppressors | Q38132688 |
| | Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice. | Q38194742 |
| | The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer. | Q38391671 |
| | Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells. | Q39001029 |
| | Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells | Q39363215 |
| | Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study | Q41043496 |
| | The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy. | Q41380085 |
| | Statin use and risk of prostate cancer recurrence in men treated with radiation therapy | Q43084888 |
| | Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy | Q43160142 |
| | Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. | Q43163981 |
| | Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy | Q43449584 |
| | Is statin use associated with D'Amico risk groups and biochemical recurrence after radical prostatectomy? | Q43525638 |
| | Effect of statin use on outcomes of non-muscle-invasive bladder cancer | Q43636779 |
| | Statin use after diagnosis of breast cancer and survival: a population-based cohort study | Q44386375 |
| | Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy | Q44882770 |
| | Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. | Q45951908 |
| | No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer | Q46414473 |
| | Relationship of statins to clinical presentation and biochemical outcomes after radical prostatectomy in Korean patients | Q46892598 |
| | Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis | Q47361125 |
| | Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 |
| | Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy | Q57540038 |
| | Use of statins and outcome of BCG treatment for bladder cancer | Q79445536 |
| | Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer | Q80181432 |
| | Effect of statin use on biochemical outcome following radical prostatectomy | Q83755810 |
| | Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy | Q84186522 |
| | Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer | Q85825080 |
| | Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease | Q85959730 |
| | Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer | Q86262306 |
| | Pathological characteristics, biochemical recurrence and functional outcome in radical prostatectomy patients on statin therapy | Q86523763 |
| | Use of statins and the risk of death in patients with prostate cancer | Q86645078 |
| | Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy | Q87527196 |
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | e1523 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies | |
| P478 | volume | 94 | |